Effect of magnesium supplementation on blood pressure: A meta-analysis

European Journal of Clinical Nutrition

Volumn 66, Issue 4, 2012, Pages 411-418

  Kass, L ^a   Weekes, J ^a   Carpenter, L ^a  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

hypertension; magnesium; meta analysis; supplementation

Indexed keywords

MAGNESIUM; PLACEBO;

ADULT; BLOOD CLOTTING DISORDER; BLOOD PRESSURE REGULATION; BONE PAIN; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; EFFECT SIZE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OUTCOME ASSESSMENT; REVIEW; STUDY DESIGN; SUPPLEMENTATION; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; VISUAL IMPAIRMENT;

ADMINISTRATION, ORAL; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CONFIDENCE INTERVALS; DIETARY SUPPLEMENTS; HUMANS; HYPERTENSION; MAGNESIUM;

EID: 84859457352     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2012.4     Document Type: Review

References (38)

1. Lawes CMM, Vander Hoorn S, Rodgers A. The International Society of Hypertension, global burden of blood-pressure-related disease. Lancet 2008; 371, 1513-1518. (Pubitemid 351626187)
2. Bo S, Pisu E. Role of magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr Opin Lipidol 2008; 19, 50-56.
3. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes and carotid arterial wall thickness: the ARIC study. J Clin Epidemiol 1995; 48, 927-940.
4. Kawano Y, Matsuoka H, Takishita S, Omae T. Effects of magnesium supplementation in hypertensive patients, assessment by office, home, and ambulatory blood pressures. Hypertension 1998; 32, 260-265. (Pubitemid 28376482)
5. Altura BM. Importance of Mg in physiology and medicine and the need for ion selective electrodes. Scand J Clin Lab Invest 1994; 54(Suppl 217), 5-9. (Pubitemid 24231806)
6. Department of Health. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Report of the Panel on Dietary Reference Values, Committee on Medical Aspects of Food and Nutrition Policy. HMSO: London, 1991.
7. Bohl CH, Volpe SL. Magnesium and exercise. Crit Rev Food Sci Nutr 2002; 42, 533-563. (Pubitemid 39649733)
8. Choudhury A, Lip GYH. Exercise and hypertension. J Hum Hypertens 2005; 19, 585-587. (Pubitemid 41131658)
9. Burgess E, Lewanczuk R, Bolli P, Chockalingam A, Cutler H, Taylor G et al. Recommendations on potassium, magnesium and calcium. Canad Med Assoc J 1999; 160(Suppl 9), S35-S45. (Pubitemid 29224657)
10. Dickinson HO, Nicolson D, Campbell F, Cook JF, Beyer FR, Ford GA et al. Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev 2006; (19), CD004640.
11. Jee SH, Edgar R, Miller III, Guallar E, Singh VK, Appel LJ et al. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens 2002; 15, 691-696. (Pubitemid 34804274)
12. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. Academic Press: Orlando, 1985.
13. Morris SB. Distribution of the standardized mean change effect size for meta-analysis on repeated measures. Br J Math Stat Psychol 2000; 53 (Part 1), 17-29.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7, 177-187.
15. Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G, Salinas-Martinez AM, Montes-Villarreal J, Trevino-Ortiz JH et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diab Metab 2004; 30, 253-258. (Pubitemid 38917455)
16. Henderson DG, Schierup J, Schodt T. Effect of magnesium supplementation on blood pressure and electrolyte concentrations in hypertensive patients receiving long term diuretic treatment. Br Med J 1986; 293, 664-665. (Pubitemid 16024166)
17. Doyle L, Flynn A, Cashman K. The effect of magnesium supplementation on biochemical markers of bone metabolism or blood pressure in healthy young adult females. Eur J Clin Nutr 1999; 53, 255-261. (Pubitemid 29164255)
18. Sacks FM, Willett WC, Smith A, Brown LE, Rosner B, Moore TJ. Effect on blood pressure of potassium, calcium and magnesium in women with low habitual intake. Hypertension 1998; 31, 131-138. (Pubitemid 28124705)
19. Witteman JCM, Grobbee DE, Derkx FHM, Bouillon R, de Bruijn AM, Hofman A. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr 1994; 60, 129-135. (Pubitemid 24215766)
20. Guerrero-Romero F, Rodriguez-Moran M. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. J Hum Hypertens 2009; 23, 245-251.
21. Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. Diabetes Care 2003; 26, 1147-1152. (Pubitemid 36929263)
22. Purvis JR, Cummings DM, Landsman P, Carroll R, Barakat H, Bray J et al. Effect of oral magnesium supplementation on selected cardiovascular risk factors in non-insulin-dependent diabetics. Arch Family Med 1994; 3, 503-508.
23. Hattori K, Saito K, Sano H, Fukuzaki H. Intracellular magnesium deficiency and effect of oral magnesium on blood pressure and red cell sodium transport in diuretic-treated hypertensive patients. Jpn Circ J 1988; 52, 1249-1256.
24. Borrello G, Mastroroberto P, Curcio F, Chello M, Zofrea S, Mazza ML. The effects of magnesium oxide on mild essential hypertension and quality of life. Curr Ther Res 1996; 57, 767-774. (Pubitemid 26373309)
25. Zemel PC, Zemel MB, Urberg M, Douglas FL, Geiser R, Sowers JR. Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension. Am J Clin Nutr 1990; 51, 665-669.
26. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288, 2981-2997.
27. Mizushima S, Cappuccio FP, Nichols R, Elliott P. Dietary magnesium intake and blood pressure: a qualitative overview of the observational studies. J Hum Hypertens 1998; 12, 447-453. (Pubitemid 28360712)
28. Lee S, Park HK, Son SP, Lee CW, Kim IJ, Kim HJ. Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults. Nutr Metab Cardiovasc Dis 2009; 19, 781-788.
29. Lind L, Lithell H, Pollare T, Ljunghall S. Blood pressure response during long-term treatment with magnesium is dependent on magnesium status. Am J Hypertens 1991; 4, 674-679.
30. Ferrara LA, Iannuzzi R, Castaldo A, Iannuzzi A, Russo AD, Mancini M. Long-term magnesium supplementation in essential hypertension. Cardiology 1992; 81, 25-33.
31. Wirell MP, Wester PO, Stegmayr BG. Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: a double-blind cross-over study. J Intern Med 1994; 236, 189-195. (Pubitemid 24246976)
32. Plum-Wirell M, Stegmay BG, Weste PO. Nutritional magnesium supplementation does not change blood pressure nor serum or muscle potassium and magnesium in untreated hypertension. A double-blind crossover study. Magn Res 1994; 7, 277-283.
33. Itoh K, Kawasaki T, Nakamur M. The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr 1997; 78, 737-750. (Pubitemid 27483017)
34. Sanjuliani AF, Fagundes VGA, Francischetti EA. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients. Intern J Cardiol 1996; 56, 177-183. (Pubitemid 26317280)
35. Paolisso G, Di Maro G, Cozzolino D, Salvatore T, D'Amore A, Lama D et al. Chronic magnesium administration enhances oxidative glucose metabolism in thiazide treated hypertensive patients. Am J Hypertens 1992; 5, 681-686.
36. Cappuccio FP, Markandu ND, Beynon GW, Shore AC, Sampson B, MacGregor GA. Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J 1985; 291, 235-238. (Pubitemid 15045050)
37. Widman L, Wester PO, Stegmayr BK, Wirell M. The dose-dependent reduction in blood pressure through administration of magnesium. Am J Hypertens 1993; 6, 41-45.
38. Nielsen FH, Lukaski HC. Update on the relationship between magnesium and exercise. Magn Res 2006; 19, 180-189. (Pubitemid 44788513)